Physician profile

Michael J Babcock

Cardiovascular Disease · Savannah, GA

NPI 1316129661

$15,286.32

in general payments reported to CMS, 2019-2025

37 companies · $8,028 in 2025

The $8,028 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$5,160.00
Food and Beverage$5,006.83
Travel and Lodging$1,690.03

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $8,582.39 2024-2025 Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia
Boston Scientific Corporation $1,331.76 2019-2024 Opticross
Abiomed $820.41 2022-2025 Impella
E.R. Squibb & Sons, L.L.C. $799.86 2019-2025 Camzyos, Eliquis
Novartis Pharmaceuticals Corporation $746.16 2019-2025
Abbott Laboratories $653.52 2019-2025 Gallant, Aveir, Unify Assura
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $400.35 2019-2025 Lifevest
Inari Medical, INC. $373.23 2020-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Medtronic, INC. $222.63 2024-2025 Onyx Frontier, Ffrangio
Livanova USA, INC. $130.62 2025 Vns Therapy Sentiva Model 1000 Generator
Ge Healthcare $119.39 2019
Shockwave Medical, INC $108.33 2024-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Pfizer INC. $102.25 2019-2025
Lexicon Pharmaceuticals, INC. $101.06 2023-2024 Inpefa
Siemens Medical Solutions USA, INC. $76.79 2019
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Philips North America LLC $76.18 2022-2025 Ecc Solutions
Astrazeneca Pharmaceuticals LP $65.68 2019
Sanofi-Aventis U.S. LLC $56.38 2019-2022
Amgen INC. $51.66 2019-2023 Repatha
Cvrx, INC. $50.62 2024-2025 Barostim Neo System
Janssen Pharmaceuticals, INC $47.20 2019-2020
Stryker Corporation $44.54 2025 Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit
Boehringer Ingelheim Pharmaceuticals, INC. $37.18 2019-2023 Jardiance
Esperion Therapeutics, INC. $30.36 2021
Akcea Therapeutics, INC. $30.25 2019
Chiesi USA, INC. $29.80 2019-2021
Bayer Healthcare Pharmaceuticals INC. $27.74 2021-2022
Alnylam Pharmaceuticals INC. $22.08 2019
Recor Medical INC $22.00 2024 Paradise Renal Denervation System
Cardiovascular Systems INC. $19.59 2019
Supernus Pharmaceuticals, INC. $18.49 2019
Amarin Pharma, INC. $17.07 2020
Acist Medical Systems, INC. $16.07 2019
Kiniksa Pharmaceuticals, LTD. $15.47 2023 Arcalyst
Medtronic Vascular, INC. $14.47 2019
Actelion Pharmaceuticals US, INC. $13.57 2020
Regeneron Healthcare Solutions, INC. $11.17 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael J Babcock

$15,286.32

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation
Context
The $8,028 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/685270/michael-j-babcock

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.